Despite public opinion, the wellness industry is profoundly and almost absurdly commercial. It sells, among its products and services, supplements, programs, retreats, coaching, devices, courses, books, subscriptions, and, perhaps most importantly for this distinction, therapeutic identities. Capitalism with yoga is still capitalism.
There is a tale, often retold in modern healthcare discourse: the tension between not only two competing industries, but, more importantly, two different ideologies concerning the nature of the scientific method and its philosophical foundations. The first, and often most popularly conceived as villainous, is the pharmaceutical industry. The colloquial term for this antipathy is “Big Pharma,” which is treated as morally suspect a priori, and anything it produces is treated with the same inherited moral skepticism. While no industry is beyond scrutiny, including the pharmaceutical one, the overemphasis on its profitability, its motives, whether apparent or hidden, and its legible failures is pronounced to a degree that is not afforded to a rival adjacent industry: the global wellness industry.
The answer, I believe, is multifaceted. When the wellness industry appears, it does not wrap itself in the cold, hard language of science, but in the terminology of natural healing, holism, ancient wisdom, mind-body balance, or even a narrative of resistance to “Big Pharma.” Suddenly, people become far less demanding, and the performative outrage projected against the capitalistic practices of the pharmaceutical industry is seldom, if ever, applied to this industry.
The double standard is not merely rhetorical; it is epistemological. With regard to pharmaceutical medicine, evidence of efficacy and safety is often treated as insufficient and filtered through concerns about industry funding, regulatory capture, selective publication, commercial incentives, and lobbying. Yet with regard to the wellness industry, the mere existence of some tentative evidence is often treated as enough. A small-sample study, or, if one is fortunate, a plausible scientifically based mechanism, may be granted disproportionate authority. In many cases, the authority comes less from rigorous scientific demonstration than from personal testimony, marketing, and many of the same practices that ironically mar the pharmaceutical industry.
The primary problem is not that wellness claims should be rejected automatically; no claim should be. The problem is that wellness claims should not be allowed epistemological exceptionalism simply because they appear more humane, more natural, or in some other way more ideologically attractive.
The challenge is that wellness culture often converts aesthetic preference into epistemological privilege. When a claim is presented as natural, holistic, ancient, or spiritually resonant, it is not merely described differently; it is judged differently. Its failures, if they are recognized at all, are interpreted more charitably. Its evidential foundations are treated more generously. Its commercial structure is often rendered less visible.
This helps create the illusion that the wellness industry exists outside the ordinary pressures of markets, status, branding, and institutional self-interest. However, let us be clear: it is not outside these forces. It is part of these forces, just like any other industry. And just like any other industry that makes claims about health, wellness, or longevity, it deserves no epistemological privilege or exception of any kind. It has done nothing to earn that. It should be held to the same evidential and scientific standard as any other field of inquiry, rather than judged by the moral, aesthetic, and emotional atmosphere surrounding its narrative.
One of the most striking and hypocritical features of this double standard is the way profit is moralized. In pharmaceutical medicine, profit is often treated as if it contaminates the claim before the evidence is even examined — a classic “poisoning the well” fallacy. The existence of commercial realities and incentives becomes, for many critics, a substitute for scientific refutation, as if profit and science were mutually exclusive. Ironically, the wellness industry is also profoundly and almost absurdly commercial. It sells, among its products and services, supplements, programs, retreats, coaching, devices, courses, books, subscriptions, and, perhaps most importantly for this distinction, therapeutic identities. Capitalism with yoga is still capitalism.
Share this article
If profit is enough to place pharmaceutical claims under suspicion, then intellectual consistency requires that the wellness industry be placed under the same suspicion — and arguably even more. To refuse to hold the wellness industry to the same standard is itself intellectually suspect, and cautiously morally suspect as well.
A consistent standard does not require hostility toward wellness any more than it requires reverence for pharmaceutical medicine. It requires proportionality. It is entirely possible and consistent that some wellness products and practices may be harmless, comforting, or even, in the best-case scenarios, useful adjuncts. It is acknowledged that they may bring people a subjective sense of relaxation, coping, or comfort beyond what scientific medicine can always provide.
However, comfort is not synonymous with scientific legitimacy, and emotional appeal is not synonymous with truth. The most salient and central question is this: do the claims being made stand up to the most rigorous scrutiny? Once wellness makes claims about health, healing, disease, pain, longevity, immunity, or recovery, it inevitably enters the domain of scientific accountability. At that point, it should not be given any quarter because of atmosphere, branding, ideology, or feelings. It should be judged just as harshly as the pharmaceutical industry is judged — by the ultimate standard: evidence.
In conclusion, the issue is not that one industry is pure and the other corrupt. That binary way of thinking is part of the problem. The conclusion is that no industry, movement, therapeutic modality, or ideology should be allowed to determine its own legitimacy outside the scientific method. It is not enough to be exonerated by self-moralizing narratives and aesthetic pretensions. Pharmaceutical medicine must be scrutinized, and so must wellness. Yes, profit must be examined, but it must be examined consistently. Evidence is also paramount, but evidence itself requires careful understanding and proportional interpretation.
Whenever a claim concerns health, suffering, disease, or treatment, it must yield to science and not to branding. Otherwise, the human cost may be branded on one’s conscience. The wellness industry’s moral hall pass should not end because it is inherently corrupt, but because no field of inquiry that makes claims with profound consequences for human health deserves exemption from the ordinary demands of truth.
BJ Saylor writes as both an independent scholar and a chronic pain patient, focusing on medicine, pain policy, scientific reasoning, and the critique of pseudoscientific and anti-scientific narratives that distort patient care.
A version of this article was originally posted at American Council on Science and Health and has been reposted here with permission. Any reposting should credit the original author and provide links to both the GLP and the original article. Find American Council on Science and Health on X @ACSHorg
